Video Experimental Relacionado

Updated: Sep 9, 2025

Lipidomics and Transcriptomics in Neurological Diseases

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

La lipidación proteica alterada en el cáncer: un vínculo oculto con la disfunción neuronal sensorial

Iman H Ibrahim¹, Ahmed Abdellatif², Heba A Eassa³

¹Department of Biochemistry and Molecular Biology, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt.

Computational biology and chemistry

|August 31, 2025

Resumen

La lipidación proteica alterada en pacientes con cáncer está relacionada con problemas neurológicos, que afectan la regeneración neuronal y las vías sensoriales. Esto puede implicar proteínas clave como el factor de alargamiento traslacional EF-1 y STAT1, que afectan la función cerebral del paciente.

Área de la Ciencia:

La bioquímica
En el campo de la oncología
La neurociencia

Sus antecedentes:

La lipidación / deslipidación de proteínas regula la función de las proteínas y los procesos celulares.
La desregulación está implicada en la progresión del cáncer y la neurodegeneración.
No se ha explorado el vínculo entre la lipidación alterada y la disfunción neurológica en pacientes con cáncer.

Objetivo del estudio:

Investigar la asociación entre la lipidación proteica alterada y los problemas neurológicos en pacientes con cáncer.
Explorar el papel de las vías específicas dependientes de la lipidación en los síntomas neurológicos relacionados con el cáncer.

Principales métodos:

Análisis bioinformático de los conjuntos de datos públicos sobre el cáncer.
Identificación y análisis de genes expresados diferencialmente (DEG) relacionados con la lipidación de proteínas.
Ontología genética y análisis de enriquecimiento de vías, incluido el análisis de objetivos de factores de transcripción.

Principales resultados:

Los DEG asociados con la lipidación alterada se enriquecieron en la regeneración / degeneración neuronal, la señalización olfativa y las vías de percepción sensorial.
Los objetivos del factor de alargamiento traslacional EF-1 (TEF1) y del transductor y activador de la transcripción 1 (STAT1) se enriquecieron significativamente.
TEF1 y STAT1, ambos que requieren lipidación, fueron identificados como factores potencialmente críticos.

Conclusiones:

La lipidación proteica alterada en pacientes con cáncer se correlaciona con la disfunción neurológica.
La desregulación afecta a los objetivos posteriores de las proteínas dependientes de la lipidación como TEF1 y STAT1.
Estas alteraciones afectan a las vías cruciales para las funciones neurológicas, sensoriales y motoras.

Palabras clave:

El cáncer Los genes expresados diferencialmente Palmitoilación Deslipidación de las proteínas La lipidación de las proteínas Percepción sensorial

Más Videos Relacionados

Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions

Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions

Published on: April 21, 2016

Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models

Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models

Published on: March 24, 2019

Videos de Conceptos Relacionados

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Covalently Linked Protein Regulators

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Notch Signaling Pathway

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...